Search details
1.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 33-43, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31838010
2.
Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07).
Eur J Cancer Care (Engl)
; 29(4): e13253, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32578279
3.
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
Breast Cancer Res Treat
; 174(3): 693-701, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30607629
4.
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.
Eur J Cancer
; 174: 232-242, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36067616
5.
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.
Cancers (Basel)
; 14(19)2022 Sep 27.
Article
in English
| MEDLINE | ID: mdl-36230628
6.
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.
Front Oncol
; 11: 744112, 2021.
Article
in English
| MEDLINE | ID: mdl-34804931
7.
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial.
Clin Cancer Res
; 26(22): 5820-5829, 2020 11 15.
Article
in English
| MEDLINE | ID: mdl-32938620
8.
Plasmablastic lymphoma of the oral cavity and jaws.
AIDS
; 16(14): 1979-80, 2002 Sep 27.
Article
in English
| MEDLINE | ID: mdl-12351965
Results
1 -
8
de 8
1
Next >
>>